Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-FreazeF: Adalimumab for Early Stage Frozen Shoulder
NCT05299242Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jul 2022
- Primary completion
- May 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in adhesive capsulitis (AC), sponsored by University of Oxford. Started Jul 2022; status: completed.
02
Drugs
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT05299242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05299242.